CD5+ diffuse large B-cell lymphoma has heterogeneous clinical features and poor prognosis: a single-center retrospective study in China

OBJECTIVE: De novo CD5-positive (CD5+) diffuse large B-cell lymphoma (DLBCL) has different clinical characteristics compared with CD5-negative (CD5−) DLBCL. However, few studies have been reported in Chinese cohorts. We investigated the clinical features and prognosis of patients with CD5+ DLBCL and...

Descripción completa

Detalles Bibliográficos
Autores principales: Yin, Ting, Qi, Ling, Zhou, Yulan, Kong, Fancong, Wang, Shixuan, Yu, Min, Li, Fei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Retrospective Clinical Research Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9483961/
https://www.ncbi.nlm.nih.gov/pubmed/36112929
http://dx.doi.org/10.1177/03000605221110075

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9483961/
https://www.ncbi.nlm.nih.gov/pubmed/36112929
http://dx.doi.org/10.1177/03000605221110075

Ejemplares similares